1	E2F-dependent	_	JJ	_	_	3	NMOD	_	_
2	histone	_	NN	_	_	3	NMOD	_	_
3	acetylation	_	NN	_	_	0	ROOT	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	recruitment	_	NN	_	_	4	CONJ	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	the	_	DT	_	_	10	NMOD	_	_
8	Tip60	_	NN	_	_	10	NMOD	_	_
9	acetyltransferase	_	NN	_	_	10	NMOD	_	_
10	complex	_	NN	_	_	6	PMOD	_	_
11	to	_	TO	_	_	5	NMOD	_	_
12	chromatin	_	NN	_	_	11	PMOD	_	_
13	in	_	IN	_	_	12	NMOD	_	_
14	late	_	JJ	_	_	15	NMOD	_	_
15	G1	_	NN	_	_	13	PMOD	_	_
16	.	_	.	_	_	3	P	_	_
		
1	E2F	_	NN	_	_	2	NMOD	_	_
2	proteins	_	NNS	_	_	3	VMOD	_	_
3	can	_	MD	_	_	0	ROOT	_	_
4	either	_	CC	_	_	5	DEP	_	_
5	activate	_	VB	_	_	3	VC	_	_
6	or	_	CC	_	_	5	COORD	_	_
7	repress	_	VB	_	_	6	CONJ	_	_
8	transcription	_	NN	_	_	7	VMOD	_	_
9	.	_	.	_	_	3	P	_	_
		
1	Following	_	VBG	_	_	9	VMOD	_	_
2	mitogenic	_	JJ	_	_	3	NMOD	_	_
3	stimulation	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	9	P	_	_
5	repressive	_	JJ	_	_	8	NMOD	_	_
6	E2F4-p130-histone	_	NN	_	_	8	NMOD	_	_
7	deacetylase	_	NN	_	_	8	NMOD	_	_
8	complexes	_	NNS	_	_	9	VMOD	_	_
9	dissociate	_	VBP	_	_	0	ROOT	_	_
10	from	_	IN	_	_	9	VMOD	_	_
11	,	_	,	_	_	9	P	_	_
12	while	_	IN	_	_	9	VMOD	_	_
13	activating	_	JJ	_	_	14	NMOD	_	_
14	species	_	NNS	_	_	23	VMOD	_	_
15	(	_	(	_	_	16	P	_	_
16	E2F1	_	NN	_	_	14	PRN	_	_
17	,	_	,	_	_	16	P	_	_
18	-2	_	CD	_	_	16	COORD	_	_
19	,	_	,	_	_	18	P	_	_
20	and	_	CC	_	_	18	COORD	_	_
21	-3	_	CD	_	_	20	CONJ	_	_
22	)	_	)	_	_	16	P	_	_
23	associate	_	VBP	_	_	12	SUB	_	_
24	with	_	IN	_	_	23	VMOD	_	_
25	,	_	,	_	_	27	P	_	_
26	target	_	NN	_	_	27	NMOD	_	_
27	promoters	_	NNS	_	_	24	PMOD	_	_
28	.	_	.	_	_	9	P	_	_
		
1	Histones	_	NNS	_	_	6	VMOD	_	_
2	H3	_	NN	_	_	1	NMOD	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	H4	_	NN	_	_	3	CONJ	_	_
5	simultaneously	_	RB	_	_	6	VMOD	_	_
6	become	_	VBP	_	_	0	ROOT	_	_
7	hyperacetylated	_	JJ	_	_	6	VMOD	_	_
8	,	_	,	_	_	6	P	_	_
9	but	_	CC	_	_	6	COORD	_	_
10	it	_	PRP	_	_	11	VMOD	_	_
11	remains	_	VBZ	_	_	9	CONJ	_	_
12	unclear	_	JJ	_	_	11	VMOD	_	_
13	whether	_	IN	_	_	11	VMOD	_	_
14	this	_	DT	_	_	15	VMOD	_	_
15	is	_	VBZ	_	_	13	SUB	_	_
16	a	_	DT	_	_	17	NMOD	_	_
17	prerequisite	_	NN	_	_	15	VMOD	_	_
18	or	_	CC	_	_	17	COORD	_	_
19	a	_	DT	_	_	20	NMOD	_	_
20	consequence	_	NN	_	_	18	CONJ	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	E2F	_	NN	_	_	23	NMOD	_	_
23	binding	_	NN	_	_	21	PMOD	_	_
24	.	_	.	_	_	6	P	_	_
		
1	Here	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	show	_	VBP	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	activating	_	JJ	_	_	8	NMOD	_	_
7	E2F	_	NN	_	_	8	NMOD	_	_
8	species	_	NNS	_	_	9	VMOD	_	_
9	are	_	VBP	_	_	5	SUB	_	_
10	required	_	VBN	_	_	9	VC	_	_
11	for	_	IN	_	_	10	VMOD	_	_
12	hyperacetylation	_	NN	_	_	11	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	target	_	NN	_	_	15	NMOD	_	_
15	chromatin	_	NN	_	_	13	PMOD	_	_
16	in	_	IN	_	_	12	NMOD	_	_
17	human	_	JJ	_	_	18	NMOD	_	_
18	cells	_	NNS	_	_	16	PMOD	_	_
19	.	_	.	_	_	4	P	_	_
		
1	Overexpression	_	NN	_	_	14	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	a	_	DT	_	_	9	NMOD	_	_
4	dominant-negative	_	JJ	_	_	9	NMOD	_	_
5	(	_	(	_	_	9	P	_	_
6	DN	_	JJ	_	_	9	NMOD	_	_
7	)	_	)	_	_	9	P	_	_
8	E2F1	_	NN	_	_	9	NMOD	_	_
9	mutant	_	NN	_	_	2	PMOD	_	_
10	in	_	IN	_	_	1	NMOD	_	_
11	serum-stimulated	_	JJ	_	_	13	NMOD	_	_
12	T98G	_	NN	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	10	PMOD	_	_
14	blocked	_	VBD	_	_	0	ROOT	_	_
15	all	_	DT	_	_	17	NMOD	_	_
16	E2F	_	NN	_	_	17	NMOD	_	_
17	binding	_	NN	_	_	14	VMOD	_	_
18	,	_	,	_	_	17	P	_	_
19	H4	_	NN	_	_	20	NMOD	_	_
20	acetylation	_	NN	_	_	17	COORD	_	_
21	,	_	,	_	_	20	P	_	_
22	and	_	CC	_	_	20	COORD	_	_
23	,	_	,	_	_	22	P	_	_
24	albeit	_	IN	_	_	25	AMOD	_	_
25	partially	_	RB	_	_	28	NMOD	_	_
26	,	_	,	_	_	28	P	_	_
27	H3	_	NN	_	_	28	NMOD	_	_
28	acetylation	_	NN	_	_	22	CONJ	_	_
29	.	_	.	_	_	14	P	_	_
		
1	Target	_	NN	_	_	3	NMOD	_	_
2	gene	_	NN	_	_	3	NMOD	_	_
3	activation	_	NN	_	_	7	VMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	S-phase	_	NN	_	_	6	NMOD	_	_
6	entry	_	NN	_	_	4	CONJ	_	_
7	were	_	VBD	_	_	0	ROOT	_	_
8	also	_	RB	_	_	7	VMOD	_	_
9	blocked	_	VBN	_	_	7	VC	_	_
10	by	_	IN	_	_	9	VMOD	_	_
11	DN	_	JJ	_	_	12	NMOD	_	_
12	E2F1	_	NN	_	_	10	PMOD	_	_
13	.	_	.	_	_	7	P	_	_
		
1	Conversely	_	RB	_	_	8	VMOD	_	_
2	,	_	,	_	_	8	P	_	_
3	ectopic	_	JJ	_	_	4	NMOD	_	_
4	activation	_	NN	_	_	8	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	E2F1	_	NN	_	_	5	PMOD	_	_
7	rapidly	_	RB	_	_	8	VMOD	_	_
8	induced	_	VBD	_	_	0	ROOT	_	_
9	H3	_	NN	_	_	12	NMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	H4	_	NN	_	_	10	CONJ	_	_
12	acetylation	_	NN	_	_	8	VMOD	_	_
13	,	_	,	_	_	8	P	_	_
14	demonstrating	_	VBG	_	_	8	VMOD	_	_
15	a	_	DT	_	_	17	NMOD	_	_
16	direct	_	JJ	_	_	17	NMOD	_	_
17	role	_	NN	_	_	14	VMOD	_	_
18	for	_	IN	_	_	17	NMOD	_	_
19	E2F	_	NN	_	_	18	PMOD	_	_
20	in	_	IN	_	_	17	NMOD	_	_
21	these	_	DT	_	_	22	NMOD	_	_
22	events	_	NNS	_	_	20	PMOD	_	_
23	.	_	.	_	_	8	P	_	_
		
1	E2F1	_	NN	_	_	2	VMOD	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	previously	_	RB	_	_	2	VMOD	_	_
4	shown	_	VBN	_	_	2	VC	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	bind	_	VB	_	_	5	IM	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	histone	_	NN	_	_	9	NMOD	_	_
9	acetyltransferases	_	NNS	_	_	6	VMOD	_	_
10	(	_	(	_	_	11	P	_	_
11	HATs	_	NNS	_	_	9	PRN	_	_
12	)	_	)	_	_	11	P	_	_
13	p300/CBP	_	NN	_	_	9	APPO	_	_
14	and	_	CC	_	_	13	COORD	_	_
15	PCAF/GCN5	_	NN	_	_	14	CONJ	_	_
16	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	9	VMOD	_	_
2	our	_	PRP$	_	_	3	NMOD	_	_
3	hands	_	NNS	_	_	1	PMOD	_	_
4	,	_	,	_	_	9	P	_	_
5	ectopically	_	RB	_	_	6	AMOD	_	_
6	expressed	_	VBN	_	_	7	NMOD	_	_
7	E2F1	_	NN	_	_	9	VMOD	_	_
8	also	_	RB	_	_	9	VMOD	_	_
9	bound	_	VBD	_	_	0	ROOT	_	_
10	the	_	DT	_	_	13	NMOD	_	_
11	unrelated	_	JJ	_	_	13	NMOD	_	_
12	HAT	_	NN	_	_	13	NMOD	_	_
13	Tip60	_	NN	_	_	9	VMOD	_	_
14	and	_	CC	_	_	9	COORD	_	_
15	induced	_	VBD	_	_	14	CONJ	_	_
16	recruitment	_	NN	_	_	15	VMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	five	_	CD	_	_	19	NMOD	_	_
19	subunits	_	NNS	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	the	_	DT	_	_	23	NMOD	_	_
22	Tip60	_	NN	_	_	23	NMOD	_	_
23	complex	_	NN	_	_	20	PMOD	_	_
24	(	_	(	_	_	25	P	_	_
25	Tip60	_	NN	_	_	23	PRN	_	_
26	,	_	,	_	_	25	P	_	_
27	TRRAP	_	NN	_	_	25	COORD	_	_
28	,	_	,	_	_	27	P	_	_
29	p400	_	NN	_	_	27	COORD	_	_
30	,	_	,	_	_	29	P	_	_
31	Tip48	_	NN	_	_	29	COORD	_	_
32	,	_	,	_	_	31	P	_	_
33	and	_	CC	_	_	31	COORD	_	_
34	Tip49	_	NN	_	_	33	CONJ	_	_
35	)	_	)	_	_	25	P	_	_
36	to	_	TO	_	_	16	NMOD	_	_
37	target	_	NN	_	_	38	NMOD	_	_
38	promoters	_	NNS	_	_	36	PMOD	_	_
39	in	_	FW	_	_	15	VMOD	_	_
40	vivo	_	FW	_	_	39	AMOD	_	_
41	.	_	.	_	_	9	P	_	_
		
1	Moreover	_	RB	_	_	9	VMOD	_	_
2	,	_	,	_	_	9	P	_	_
3	E2F-dependent	_	JJ	_	_	4	NMOD	_	_
4	recruitment	_	NN	_	_	9	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	Tip60	_	NN	_	_	5	PMOD	_	_
7	to	_	TO	_	_	4	NMOD	_	_
8	chromatin	_	NN	_	_	7	PMOD	_	_
9	occurred	_	VBD	_	_	0	ROOT	_	_
10	in	_	IN	_	_	9	VMOD	_	_
11	late	_	JJ	_	_	12	NMOD	_	_
12	G(1)	_	NN	_	_	10	PMOD	_	_
13	following	_	VBG	_	_	9	VMOD	_	_
14	serum	_	NN	_	_	15	NMOD	_	_
15	stimulation	_	NN	_	_	13	PMOD	_	_
16	.	_	.	_	_	9	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	speculate	_	VBP	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	activities	_	NNS	_	_	10	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	multiple	_	JJ	_	_	9	NMOD	_	_
8	HAT	_	NN	_	_	9	NMOD	_	_
9	complexes	_	NNS	_	_	6	PMOD	_	_
10	account	_	VBP	_	_	3	SUB	_	_
11	for	_	IN	_	_	10	VMOD	_	_
12	E2F-dependent	_	JJ	_	_	13	NMOD	_	_
13	acetylation	_	NN	_	_	11	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	transcription	_	NN	_	_	13	COORD	_	_
16	,	_	,	_	_	15	P	_	_
17	and	_	CC	_	_	15	COORD	_	_
18	S-phase	_	NN	_	_	19	NMOD	_	_
19	entry	_	NN	_	_	17	CONJ	_	_
20	.	_	.	_	_	2	P	_	_
		
